{"entity":{"type":"insider","cik":"0001554767","url":"/insider/0001554767","json_url":"/insider/0001554767.json","name":"Bergstein Ivan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":33,"n_filings":23,"first":"2014-09-03","last":"2020-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Bergstein Ivan","source":"filing","n_filings":23,"first_seen":"2014-09-03","last_seen":"2020-04-20"}],"transactions":[{"id":2339619,"accession":"0001104659-20-048399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-048399","line_url":"/filing/0001104659-20-048399#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53618.0,"shares_display":"53,618","price_per_share":4.88,"price_display":"4.88","price_state":"stated","total_value":261655.84,"total_display":"261,655.84","total_whole":"261,656","shares_owned_after":2804336.0,"shares_owned_after_display":"2,804,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-15","filed_date":"2020-04-20","scope":"insider"},{"id":2912114,"accession":"0001104659-20-033489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-033489","line_url":"/filing/0001104659-20-033489#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36542.0,"shares_display":"36,542","price_per_share":4.92,"price_display":"4.92","price_state":"stated","total_value":179786.64,"total_display":"179,786.64","total_whole":"179,787","shares_owned_after":2857954.0,"shares_owned_after_display":"2,857,954","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-10","filed_date":"2020-03-13","scope":"insider"},{"id":2912109,"accession":"0001104659-20-033489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-033489","line_url":"/filing/0001104659-20-033489#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20909.0,"shares_display":"20,909","price_per_share":5.09,"price_display":"5.09","price_state":"stated","total_value":106426.81,"total_display":"106,426.81","total_whole":"106,427","shares_owned_after":2894496.0,"shares_owned_after_display":"2,894,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-13","scope":"insider"},{"id":2806036,"accession":"0001104659-20-027398","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-027398","line_url":"/filing/0001104659-20-027398#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24642.0,"shares_display":"24,642","price_per_share":6.42,"price_display":"6.42","price_state":"stated","total_value":158201.64,"total_display":"158,201.64","total_whole":"158,202","shares_owned_after":2915405.0,"shares_owned_after_display":"2,915,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-25","filed_date":"2020-02-28","scope":"insider"},{"id":2789906,"accession":"0001104659-20-000978","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-000978","line_url":"/filing/0001104659-20-000978#line-4","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2446.0,"shares_display":"2,446","price_per_share":10.48,"price_display":"10.48","price_state":"stated","total_value":25634.08,"total_display":"25,634.08","total_whole":"25,634","shares_owned_after":2514773.0,"shares_owned_after_display":"2,514,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2020-01-03","scope":"insider"},{"id":2789900,"accession":"0001104659-20-000978","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-000978","line_url":"/filing/0001104659-20-000978#line-3","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18744.0,"shares_display":"18,744","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":201498.0,"total_display":"201,498.00","total_whole":"201,498","shares_owned_after":2517219.0,"shares_owned_after_display":"2,517,219","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2020-01-03","scope":"insider"},{"id":2789893,"accession":"0001104659-20-000978","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-000978","line_url":"/filing/0001104659-20-000978#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29613.0,"shares_display":"29,613","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":324854.61,"total_display":"324,854.61","total_whole":"324,855","shares_owned_after":2535963.0,"shares_owned_after_display":"2,535,963","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-24","filed_date":"2020-01-03","scope":"insider"},{"id":2789888,"accession":"0001104659-20-000978","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-000978","line_url":"/filing/0001104659-20-000978#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5225.0,"shares_display":"5,225","price_per_share":10.58,"price_display":"10.58","price_state":"stated","total_value":55280.5,"total_display":"55,280.50","total_whole":"55,281","shares_owned_after":2565576.0,"shares_owned_after_display":"2,565,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-23","filed_date":"2020-01-03","scope":"insider"},{"id":8310278,"accession":"0001104659-19-046425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-046425","line_url":"/filing/0001104659-19-046425#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35010.0,"shares_display":"35,010","price_per_share":14.73,"price_display":"14.73","price_state":"stated","total_value":515697.3,"total_display":"515,697.30","total_whole":"515,697","shares_owned_after":2570801.0,"shares_owned_after_display":"2,570,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-16","scope":"insider"},{"id":8476067,"accession":"0001104659-19-038309","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-038309","line_url":"/filing/0001104659-19-038309#line-3","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16994.0,"shares_display":"16,994","price_per_share":14.77,"price_display":"14.77","price_state":"stated","total_value":251001.38,"total_display":"251,001.38","total_whole":"251,001","shares_owned_after":2605811.0,"shares_owned_after_display":"2,605,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-28","scope":"insider"},{"id":8476063,"accession":"0001104659-19-038309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-038309","line_url":"/filing/0001104659-19-038309#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28500.0,"shares_display":"28,500","price_per_share":15.1,"price_display":"15.10","price_state":"stated","total_value":430350.0,"total_display":"430,350.00","total_whole":"430,350","shares_owned_after":2622805.0,"shares_owned_after_display":"2,622,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-25","filed_date":"2019-06-28","scope":"insider"},{"id":8476057,"accession":"0001104659-19-038309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-038309","line_url":"/filing/0001104659-19-038309#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10822.0,"shares_display":"10,822","price_per_share":15.49,"price_display":"15.49","price_state":"stated","total_value":167632.78,"total_display":"167,632.78","total_whole":"167,633","shares_owned_after":2651305.0,"shares_owned_after_display":"2,651,305","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-24","filed_date":"2019-06-28","scope":"insider"},{"id":8281347,"accession":"0001104659-19-015345","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-015345","line_url":"/filing/0001104659-19-015345#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2151.0,"shares_display":"2,151","price_per_share":11.05,"price_display":"11.05","price_state":"stated","total_value":23768.55,"total_display":"23,768.55","total_whole":"23,769","shares_owned_after":2662127.0,"shares_owned_after_display":"2,662,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-12","filed_date":"2019-03-15","scope":"insider"},{"id":8281343,"accession":"0001104659-19-015345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-015345","line_url":"/filing/0001104659-19-015345#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55073.0,"shares_display":"55,073","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":611861.03,"total_display":"611,861.03","total_whole":"611,861","shares_owned_after":2664278.0,"shares_owned_after_display":"2,664,278","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-11","filed_date":"2019-03-15","scope":"insider"},{"id":8053641,"accession":"0001104659-19-013682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-013682","line_url":"/filing/0001104659-19-013682#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6800.0,"shares_display":"6,800","price_per_share":11.41,"price_display":"11.41","price_state":"stated","total_value":77588.0,"total_display":"77,588.00","total_whole":"77,588","shares_owned_after":2719351.0,"shares_owned_after_display":"2,719,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-07","filed_date":"2019-03-08","scope":"insider"},{"id":8613801,"accession":"0001104659-19-011256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-011256","line_url":"/filing/0001104659-19-011256#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22905.0,"shares_display":"22,905","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":275547.15,"total_display":"275,547.15","total_whole":"275,547","shares_owned_after":2726151.0,"shares_owned_after_display":"2,726,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-25","filed_date":"2019-02-27","scope":"insider"},{"id":8053572,"accession":"0001104659-19-009112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-009112","line_url":"/filing/0001104659-19-009112#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34132.0,"shares_display":"34,132","price_per_share":10.98,"price_display":"10.98","price_state":"stated","total_value":374769.36,"total_display":"374,769.36","total_whole":"374,769","shares_owned_after":2749056.0,"shares_owned_after_display":"2,749,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-14","filed_date":"2019-02-15","scope":"insider"},{"id":6901445,"accession":"0001104659-18-017585","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-017585","line_url":"/filing/0001104659-18-017585","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37857.0,"shares_display":"37,857","price_per_share":17.339965924399714,"price_display":"17.34","price_state":"stated","total_value":656439.09,"total_display":"656,439.09","total_whole":"656,439","shares_owned_after":2162548.0,"shares_owned_after_display":"2,162,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-12","filed_date":"2018-03-14","scope":"insider","n_lines":2},{"id":6352364,"accession":"0001104659-18-016432","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-016432","line_url":"/filing/0001104659-18-016432#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6797.0,"shares_display":"6,797","price_per_share":16.56,"price_display":"16.56","price_state":"stated","total_value":112558.32,"total_display":"112,558.32","total_whole":"112,558","shares_owned_after":2050580.0,"shares_owned_after_display":"2,050,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-07","filed_date":"2018-03-09","scope":"insider"},{"id":6493690,"accession":"0001104659-18-013697","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-18-013697","line_url":"/filing/0001104659-18-013697#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13407.0,"shares_display":"13,407","price_per_share":17.26,"price_display":"17.26","price_state":"stated","total_value":231404.82,"total_display":"231,404.82","total_whole":"231,405","shares_owned_after":2057377.0,"shares_owned_after_display":"2,057,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-27","filed_date":"2018-02-28","scope":"insider"},{"id":6493688,"accession":"0001104659-18-013697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-013697","line_url":"/filing/0001104659-18-013697#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10776.0,"shares_display":"10,776","price_per_share":17.61,"price_display":"17.61","price_state":"stated","total_value":189765.36,"total_display":"189,765.36","total_whole":"189,765","shares_owned_after":2070784.0,"shares_owned_after_display":"2,070,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-28","scope":"insider"},{"id":6516936,"accession":"0001104659-18-010449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-010449","line_url":"/filing/0001104659-18-010449#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3820.0,"shares_display":"3,820","price_per_share":15.8,"price_display":"15.80","price_state":"stated","total_value":60356.0,"total_display":"60,356.00","total_whole":"60,356","shares_owned_after":2081560.0,"shares_owned_after_display":"2,081,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-16","scope":"insider"},{"id":4183720,"accession":"0001104659-17-015591","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-015591","line_url":"/filing/0001104659-17-015591#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5401.0,"shares_display":"5,401","price_per_share":8.13,"price_display":"8.13","price_state":"stated","total_value":43910.13,"total_display":"43,910.13","total_whole":"43,910","shares_owned_after":1819095.0,"shares_owned_after_display":"1,819,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-09","scope":"insider"},{"id":5117520,"accession":"0001104659-17-013193","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-17-013193","line_url":"/filing/0001104659-17-013193#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10480.0,"shares_display":"10,480","price_per_share":7.01,"price_display":"7.01","price_state":"stated","total_value":73464.8,"total_display":"73,464.80","total_whole":"73,465","shares_owned_after":1824496.0,"shares_owned_after_display":"1,824,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-28","filed_date":"2017-03-01","scope":"insider"},{"id":5117516,"accession":"0001104659-17-013193","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-013193","line_url":"/filing/0001104659-17-013193#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":6.97,"price_display":"6.97","price_state":"stated","total_value":52275.0,"total_display":"52,275.00","total_whole":"52,275","shares_owned_after":1834976.0,"shares_owned_after_display":"1,834,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-27","filed_date":"2017-03-01","scope":"insider"},{"id":4107968,"accession":"0001104659-17-010292","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-010292","line_url":"/filing/0001104659-17-010292#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3652.0,"shares_display":"3,652","price_per_share":6.42,"price_display":"6.42","price_state":"stated","total_value":23445.84,"total_display":"23,445.84","total_whole":"23,446","shares_owned_after":1842476.0,"shares_owned_after_display":"1,842,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-02-17","scope":"insider"},{"id":3074150,"accession":"0001104659-16-104299","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-104299","line_url":"/filing/0001104659-16-104299#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5537.0,"shares_display":"5,537","price_per_share":5.34,"price_display":"5.34","price_state":"stated","total_value":29567.58,"total_display":"29,567.58","total_whole":"29,568","shares_owned_after":1846128.0,"shares_owned_after_display":"1,846,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-08","filed_date":"2016-03-10","scope":"insider"},{"id":2165257,"accession":"0001104659-16-098575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-098575","line_url":"/filing/0001104659-16-098575#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3244.0,"shares_display":"3,244","price_per_share":4.46,"price_display":"4.46","price_state":"stated","total_value":14468.24,"total_display":"14,468.24","total_whole":"14,468","shares_owned_after":1673582.0,"shares_owned_after_display":"1,673,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-19","scope":"insider"},{"id":8838997,"accession":"0001104659-15-082233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-082233","line_url":"/filing/0001104659-15-082233#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12235.0,"shares_display":"12,235","price_per_share":8.2,"price_display":"8.20","price_state":"stated","total_value":100327.0,"total_display":"100,327.00","total_whole":"100,327","shares_owned_after":1926826.0,"shares_owned_after_display":"1,926,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-30","filed_date":"2015-12-01","scope":"insider"},{"id":8199259,"accession":"0001104659-15-012682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-012682","line_url":"/filing/0001104659-15-012682#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3180.0,"shares_display":"3,180","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":44583.6,"total_display":"44,583.60","total_whole":"44,584","shares_owned_after":1888801.0,"shares_owned_after_display":"1,888,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-18","filed_date":"2015-02-20","scope":"insider"},{"id":6219641,"accession":"0001104659-14-083725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-083725","line_url":"/filing/0001104659-14-083725#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11974.0,"shares_display":"11,974","price_per_share":14.4,"price_display":"14.40","price_state":"stated","total_value":172425.6,"total_display":"172,425.60","total_whole":"172,426","shares_owned_after":1891981.0,"shares_owned_after_display":"1,891,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-26","filed_date":"2014-11-26","scope":"insider"},{"id":6277004,"accession":"0001104659-14-064461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-064461","line_url":"/filing/0001104659-14-064461#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001554767","owner_name":"Bergstein Ivan","owner_display_name":"Bergstein Ivan","owner_url":"/insider/0001554767","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":11.0543,"price_display":"11.05","price_state":"stated","total_value":22108.6,"total_display":"22,108.60","total_whole":"22,109","shares_owned_after":1903955.0,"shares_owned_after_display":"1,903,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-03","filed_date":"2014-09-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":33,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":32,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":33},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001264587","name":"STEMLINE THERAPEUTICS INC","url":"/issuer/0001264587","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":23,"first_seen":"2014-09-03","last_seen":"2020-04-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001554767","retrieved_at":"2026-08-22T22:18:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}